Atópiás dermatitisz (ekcéma): vizsgálatok itt: Magyarország
11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Where
- Békéscsaba, Budapest III, Pécs, Szeged
- Életkor
- 2 év to 11 év
- People
- 450 worldwide
- Run by
- Pfizer
See details and how to joinNCT06807281 · EU 2023-509124-18-00 - 2. fázisTaking peopleA Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Where
- Budapest, Debrecen, Szeged
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Apogee Therapeutics, Inc.
See details and how to joinNCT07003425 - 2. fázisTaking peopleA Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis
- Where
- Békéscsaba, Budapest VIII, Debrecen, Pécs, Szeged
- Életkor
- 18 év and over
- People
- 138 worldwide
- Run by
- Apollo Therapeutics Limited
See details and how to join2026-525673-39-00 · EU 2026-525673-39-00 - 2. fázisTaking peoplePlatform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Where
- Budapest III, Budapest VIII, Debrecen, Pécs, Szeged
- Életkor
- 18 év to 100 év
- People
- 224 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00 - 3. fázisTaking peopleA Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Where
- Békéscsaba, Budapest III, Pécs, Szeged
- Életkor
- 6 év to 11 év
- People
- 150 worldwide
- Run by
- Pfizer
See details and how to joinNCT06807268 · EU 2023-509121-51-00 - 3. fázisTaking peopleA Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Budapest, Debrecen, Orosháza, Pécs, Szolnok
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Nektar Therapeutics
See details and how to joinNCT07711418 · EU 2025-525129-11-00 - 1. fázisTaking peopleA Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
- Where
- Budapest II, Budapest VIII, Szeged
- Életkor
- 18 év to 64 év
- People
- 291 worldwide
- Run by
- Sanofi-Aventis Recherche & Developpement
See details and how to join2025-523826-41-00 · EU 2025-523826-41-00 - 2. fázisTaking peopleA Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Where
- Békéscsaba, Budapest, Debrecen, Pécs, Szeged
- Életkor
- 18 év to 65 év
- People
- 280 worldwide
- Run by
- Apollo Therapeutics Ltd
See details and how to joinNCT07599813 - 2. fázisTaking peopleA Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis
- Where
- Budapest VIII, Debrecen, Szeged
- Életkor
- 18 év and over
- People
- 175 worldwide
- Run by
- Apogee Therapeutics Inc.
See details and how to join2024-519795-11-00 · EU 2024-519795-11-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Where
- Budapest III, Budapest VIII, Kecskemét
- Életkor
- 18 év to 74 év
- People
- 405 worldwide
- Run by
- Inmagene LLC
See details and how to joinNCT07037901 · EU 2024-520117-50-00 - No phaseTaking peoplePALLAS Laser for Skin Diseases
- Where
- Szeged
- Életkor
- 18 év to 65 év
- People
- 50
- Run by
- Szeged University
See details and how to joinNCT07250997